2 months ago
IBRX
AnalystsKelly ShiKelly Shi's Stock Forecasts
AnalystsKelly Shi
Sectors:
Analyst Ranking
Top 19%
#937 out of 5184 analysts
Average Return
+10.41%
Win Rate
47%18 out of 38
Risk vs Reward
Poor
Good
Kelly Shi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +320.20% | $8.96 | $37.65 | 2022-11-10 - 2023-11-10 | Strong Buy |
Cogent Biosciences IncCOGT | +310.27% | $9.35 | $38.36 | 2025-07-06 - 2026-01-28 | Strong Buy |
Immunitybio IncIBRX | +160.59% | $2.36 | $6.15 | 2025-12-11 - 2026-01-28 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +142.72% | $7.21 | $17.50 | 2023-11-14 - 2024-11-14 | Strong Buy |
Insmed IncINSM | +137.24% | $65.71 | $155.89 | 2025-05-12 - 2026-01-28 | Strong Buy |
Kelly Shi Analyst Color
Get additional color on Kelly Shi's coverage of popular stocks
2 months ago
KYMR
Kelly Shi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunitybio IncIBRX | 2 | Strong Buy | $9.00 | +46.34% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $122.00 | +71.44% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 4 | Strong Buy | $77.00 | +1.85% | Maintains | 3 months ago |
Insmed IncINSM | 2 | Strong Buy | $148.00 | -5.06% | Maintains | 6 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $28.00 | -27.01% | Maintains | 7 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $44.00 | +181.33% | Maintains | 9 months ago |
Verastem IncVSTM | 1 | Strong Buy | $15.00 | +140.77% | Initiates Coverage On | 10 months ago |
Opthea LtdOPTEY | 1 | Sell | $1.00 | -70.67% | Downgrades | 10 months ago |
Instil Bio IncTIL | 2 | Strong Buy | $52.00 | N/A | Upgrades | a year ago |
Foghorn Therapeutics IncFHTX | 2 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Ascendis Pharma AASND | 2 | Strong Buy | $196.00 | N/A | Maintains | a year ago |
Artiva Biotherapeutics IncARTV | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 2 years ago |
Prokidney CorpPROK | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Incyte CorpINCY | 1 | Strong Buy | $81.00 | N/A | Initiates Coverage On | 2 years ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Immunogen IncIMGN | 2 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Beone Medicines LtdONC | 1 | Strong Buy | $287.00 | N/A | Initiates Coverage On | 2 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Sell | $3.00 | N/A | Downgrades | 3 years ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Cti Biopharma CorpCTIC | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Adicet Bio IncACET | 1 | Strong Buy | $432.00 | N/A | Initiates Coverage On | 4 years ago |
Humanigen IncHGENQ | 1 | Hold | $9.00 | N/A | Downgrades | 4 years ago |
Hutchmed LtdHCM | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | 4 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 5 years ago |
Adagene IncADAG | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 5 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.